Serious and Hematological Adverse Effects of Daratumumab Plus Triple Therapy vs Triple Therapy Alone for Multiple Myeloma: A Systematic Review and Meta-Analysis

Sadeleştirilmiş öğe sayfası
dc.contributor.authorSantos Silva, Victor Emanoel
dc.contributor.authorMaranhao, Lara de Albuquerque
dc.contributor.authorRuiz, Santiago
dc.contributor.authorde Souza Kunior, Itaja Dantas
dc.contributor.authorSahin, Oguz
dc.contributor.authorMohan, Arundhati
dc.contributor.authorMaciel, James
dc.date.accessioned2025-10-16T15:12:46Z
dc.date.issued2024
dc.identifier.otherWOS:001325737900427
dc.identifier.urihttps://openaccess.acibadem.edu.tr/handle/11443/5599
dc.publisherCIG MEDIA GROUP, LP
dc.sourceCLINICAL LYMPHOMA MYELOMA \& LEUKEMIA
dc.titleSerious and Hematological Adverse Effects of Daratumumab Plus Triple Therapy vs Triple Therapy Alone for Multiple Myeloma: A Systematic Review and Meta-Analysis
dc.typeMeeting Abstract

Dosyalar

Koleksiyonlar

WOS